Authors:
LISTON TE
CONKLYN MJ
HOUSER J
WILNER KD
JOHNSON A
APSELOFF G
WHITACRE C
SHOWELL HJ
Citation: Te. Liston et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF THE LEUKOTRIENE B-4 RECEPTORANTAGONIST CP-105,696 IN MAN FOLLOWING SINGLE ORAL-ADMINISTRATION, British journal of clinical pharmacology, 45(2), 1998, pp. 115-121
Authors:
HAMELIN BA
ALLARD S
LAPLANTE L
MICELI J
WILNER KD
TREMBLAY J
LEBEL M
Citation: Ba. Hamelin et al., THE EFFECT OF TIMING OF A STANDARD MEAL ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NOVEL ATYPICAL ANTIPSYCHOTIC AGENT ZIPRASIDONE, Pharmacotherapy, 18(1), 1998, pp. 9-15
Authors:
GOFF DC
POSEVER T
HERZ L
SIMMONS J
KLETTI N
LAPIERRE K
WILNER KD
LAW CG
KO GN
Citation: Dc. Goff et al., AN EXPLORATORY HALOPERIDOL-CONTROLLED DOSE-FINDING STUDY OF ZIPRASIDONE IN HOSPITALIZED-PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER, Journal of clinical psychopharmacology, 18(4), 1998, pp. 296-304
Citation: Ra. Ronfeld et al., PHARMACOKINETICS OF SERTRALINE AND ITS N-DEMETHYL METABOLITE IN ELDERLY AND YOUNG MALE AND FEMALE VOLUNTEERS, Clinical pharmacokinetics, 32, 1997, pp. 22-30
Citation: Lm. Tremaine et al., A STUDY OF THE POTENTIAL EFFECT OF SERTRALINE ON THE PHARMACOKINETICSAND PROTEIN-BINDING OF TOLBUTAMIDE, Clinical pharmacokinetics, 32, 1997, pp. 31-36
Authors:
GARDNER MJ
BARIS BA
WILNER KD
PRESKORN SH
Citation: Mj. Gardner et al., EFFECT OF SERTRALINE ON THE PHARMACOKINETICS AND PROTEIN-BINDING OF DIAZEPAM IN HEALTHY-VOLUNTEERS, Clinical pharmacokinetics, 32, 1997, pp. 43-49
Citation: Ra. Ronfeld et al., SERTRALINE - CHRONOPHARMACOKINETICS AND THE EFFECT OF COADMINISTRATION WITH FOOD, Clinical pharmacokinetics, 32, 1997, pp. 50-55
Citation: Mg. Ziegler et Kd. Wilner, SERTRALINE DOES NOT ALTER THE BETA-ADRENERGIC BLOCKING ACTIVITY OF ATENOLOL IN HEALTHY MALE-VOLUNTEERS, The Journal of clinical psychiatry, 57, 1996, pp. 12-15
Authors:
WILNER KD
JOHNSON AC
MICELI JJ
FRICKE JR
TITUS CK
Citation: Kd. Wilner et al., ANXIOLYTIC EFFECTS OF ZIPRASIDONE, AN ATYPICAL ANTIPSYCHOTIC, COMPARED WITH DIAZEPAM AND PLACEBO ON SUBJECTS PRIOR TO UNDERGOING MINOR DENTAL SURGERY, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 73-73
Citation: Mj. Gardner et al., SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF TENIDAP SODIUM IN HEALTHY-SUBJECTS, British journal of clinical pharmacology, 39, 1995, pp. 11-15
Citation: Kd. Wilner et Mj. Gardner, CIMETIDINE DOES NOT ALTER THE CLEARANCE OR PLASMA-BINDING OF TENIDAP IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 39, 1995, pp. 21-24
Authors:
APSELOFF G
WILNER KD
VONDEUTSCH DA
GERBER N
Citation: G. Apseloff et al., TENIDAP SODIUM DECREASES RENAL CLEARANCE AND INCREASES STEADY-STATE CONCENTRATIONS OF LITHIUM IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 39, 1995, pp. 25-28
Citation: G. Apseloff et al., EFFECT OF TENIDAP SODIUM ON THE PHARMACODYNAMICS AND PLASMA-PROTEIN BINDING OF WARFARIN IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 39, 1995, pp. 29-33
Citation: Ra. Blum et al., THE EFFECT OF TENIDAP SODIUM ON THE DISPOSITION AND PLASMA-PROTEIN BINDING OF PHENYTOIN IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 39, 1995, pp. 35-38
Citation: Kd. Wilner et Mj. Gardner, TENIDAP SODIUM DOES NOT ALTER THE CLEARANCE OR PLASMA-PROTEIN BINDINGOF TOLBUTAMIDE IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 39, 1995, pp. 39-42
Citation: Jj. Miceli et al., THE PHARMACOKINETICS (PK) OF CP-88,059 (CP) IN HEALTHY MALE-VOLUNTEERS FOLLOWING ORAL (PO) AND INTRAVENOUS (IV) ADMINISTRATION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 142-142